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Abstract. Antisera to ovine follicle stimulating hormone free of ovine lutinising hormone
contamination has been obtained in monkeys. These antisera have been shown to be able to
crossreact with ovine lutinising hormone. Quantitation of the binding data for ovine follicle
stimulating hormone and ovine lutinising hormone show that 10–40% of the total antibody 
population to ovine follicle stimulating hormone can bind to ovine lutinising hormone and 
the affinity constant for ovine lutinising hormone is about 2–20 times lesser than for ovine 
follicle stimulating hormone. These binding data indicate that there are common epitopes 
exposed in ovine follicle stimulating hormone and ovine lutinising hormone through the α- 
subunit. Results are obtained which match with the above conclusions when ovine lutinising 
hormone antisera is analysed for ovine follicle stimulating hormone binding. These results 
show that the α-subunit when combined with different ß-subunits will have common 
epitopes exposed, but would be sterically disposed differently in the two hormones.
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Introduction 
 
Termination of pregnancy in experimental animals through passive/active 
immunisation is a well documented scientific phenomenon (Stevens, 1973; Mukku et 
al., 1974; Raj et al., 1974; Sundaram et al., 1976; Adiga and Ramana Murthy, 1983; 
Sheela Rani and Moudgal, 1983; Chandana Das et al., 1985; Wickings et al., 1982). 
This method of approach to human contraception is under way in many laboratories 
(Talwar et al., 1976; Nash et al., 1980; Moudgal et al., 1985) it is desirable to learn 
more about the antisera generated for hormones in terms of specificity and cross- 
reactivity. The hormones which have a definite role in reproduction in primates and 
incidentally have structural similarity are follicle stimulating hormone (FSH), lu
tinising hormone (LH) and human chorionic gonadotropin (hCG). Thus it is of
practical value to investigate carefully into the specificities of the antisera obtained in
animals for these purified hormones.
Antiserum raised to a pure hormone is considered very specific as has been
frequently determined by its biological characterisation. Gonadotropins, specially 
FSH, LH and hCG, have a common α-subunit (molecular weight 17000) and 
variable β-subunits (molecular weight 18000-20000). On the basis of this structure 
one can assume that all the 3 hormones could have a large number of common 
epitopes (nearly 50% of the total structure is homologous), and this on the basis of 
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molecular weight should be significant. Thus the antisera raised to ovine FSH 
(oFSH) can be expected to be crossreacting immunologically with ovine LH (oLH) 
significantly. However the data presented in the literature (Rao and Moudgal, 1970; 
Moudgal et al., 1985) indicate very minimal cross reactivity in the antisera raised to 
hormones. The reason ascribed for lack of crossreactivity are many, (i) The α-subunit 
is supposed to be very poorly antigenic and hence low titres of antisera directed to 
the epitopes on the α-subunit that could be present in the whole molecule. 
(ii) During the α-, ß-complex formation most of the α-subunit is buried in the ß- 
subunit, leaving very little of the α-structure to be exposed to the solvent for eliciting 
antibody response in the animal. (iii) The α-subunit is totally non immunogenic and 
the cross reactivity is due to the contaminant hormone present in the antigen used 
for immunisation, and as such each antiserum is having noncrossreacting antibodies 
to both hormones. The last suggestion has gained value as the antigens used in most 
cases are infact highly or marginally contaminated with the other antigen. In the 
present paper we report on the nature of the immunological crossreactivity/specifi- 
city of the antisera obtained for hormone (oLH/oFSH) preparations which are 
highly purified and freed of contaminating hormones by affinity chromotography.
 
Materials and methods 
 
Bovine serum albumin (BSA) and butanediol diglycidyl ether were products from 
Sigma Chemical Company, St. Louis, Missouri, USA. Sepharose was a product of 
Pharmacia, Sweden. oFSH and oLH were prepared from locally procured sheep 
pituitaries by procedures standardised in the laboratory. The procedure essentially 
followed the method of Sairam (1979), with slight modifications. oLH was 90–100% 
pure and had <0·01% contamination of oFSH, while oFSH was 90–100% pure and 
had a oLH contamination of about 4% as measured by radioimmunoassay (RIA). 
Disc electrophoresis of these preparations gave a single diffuse band as expected for 
glycoprotein hormones with no additional band.
All the binding studies were done in 0·05 Μ phosphate buffer containing 0·1% BSA 
pH 7·2. 
 
Antisera production 
 
All antisera were raised by the conventional method using Freund's complete 
adjuvant by the standard procedure. Briefly young rabbits were immunised with 
200 µg of oLH in Freund's complete adjuvant intradermally at weekly intervals for 4 
weeks. Subsequently booster shots of 100 µg oLH in saline was administered 
subcutaneously and antisera were collected after 14 days after the booster shot. 
Antisera to oFSH were all raised in monkeys using oFSH adsorbed on commercial 
aluminium hydroxide. Male monkeys (Macaca radiata) of 5–6 years age were 
immunised with oFSH adsorbed on alugel (1 mg oFSH/ml alugel) with primary 
immunisation dose of 1 mg, 300 µg, 100 µg and 100 µg at intervals of 8 days, given 
intradermally. Booster shots were subsequently administered at 50 day intervals 
using 100 µg of oFSH adsorbed on alugel. Antisera used in the studies were collected 
from animals which were on this immunisation schedule for 150–200 days, the 
antisera being collected 14 days after the booster dose. These antisera were used for 
further studies without any further treatment.
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Immobilisation of oLH and oLH antibody on epoxy-Sepharose
 
Freshly prepared epoxy-Sepharose (EPS) (2 ml) was equilibrated with 1 Μ sodium 
carbonate and coupled to 10 mg of oLH in the same solution in a total volume of 
4 ml (Murthy and Moudgal, 1986). Coupling was allowed to occur overnight at 
room temperature. The gel was thoroughly washed and stored at 4°C until use. The 
immobilised oLH (oLH-EPS) had 5 mg oLH/ml of gel.
oLH antibody (5 ml) was coupled to freshly prepared EPS (10 ml) by the same
procedure as outlined above, using the immunoglobulin-G fraction of the antiserum. 
The gel obtained had a capacity to bind about 500 µg of oLH/ml of the gel.
 
Affinity purification of antigen (oFSH)
 
oFSH (10 mg containing 4% oLH) in 4 ml of 0·9% sodium chloride was passed
through a column of oLH antibody-EPS (2 ml) and recirculated 4–5 times before
washing the column with water. The extent of oLH removal was quantitated by 
using a standard RIA system and contamination of oLH as measured by RIA was 
<0·1%. This material was used for raising antisera in the monkeys. oLH purified 
from sheep pituitaries had <0·01% contamination and as such used for immunisa- 
tion as well as coupling to EPS. 
 
Iodination of hormones 
 
Iodination of hormones was carried out by chloramine Τ procedure (Rao et al., 
1984). The specific activity of the iodinated hormones was in the range of 50-
100 µCi/mg protein. 
 
Binding of [125I]-hormones to antisera
 
This was carried out in 0·05 Μ phosphate buffer, pH 7·2, at room temperature for
20 h in a final volume of 0·5 ml. The separation of the bound label from free label was
effected by polyethylene glycol double antibody method (double antibody precipita-
tion done in the presence of 1·25–2·5% polyethylene glycol for 20 min). The bound
radioactivity was counted in a LKB Clinigamma counter.
 
Adsorption of antibodies on oLH-EPS
 
This approach was used to prove experimentally that the crossreacting species of 
antibody present in the antisera is infact the antibody that is elicited in response to 
the antigen and not in response to the contaminated ‘antigen analogue’. We assume 
that the antigen (oLH) is pure and all the antibodies that are obtained bind to oLH 
and a part of this antibody population binds to oFSH (those species of antibodies 
that are directed to the common epitope). If this is the hypothesis, adsorption of 
antibodies by oLH-EPS should result in parallel decrease in the oLH and oFSH 
binding. Thus, if contamination of the antigen is the reason, for crossreaction, the 
above treatment results in the selective depletion of the oLH binding without 
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affecting oFSH binding. Otherwise, the depletion of the oLH and oFSH binding 
should be parallel after the oLH-EPS treatment.
Antiserum (50 µl) was taken in 200 µl of RIA buffer and mixed with 5–50 µg of the 
oLH-EPS suspension in a total volume of 0·5 ml. Control tubes had the same 
volume of the antiserum and 5–50 mg of sepharose in a total volume of 0·5 ml. The 
tubes were shaken intermittantly at room temperature for 2h. The suspension was 
diluted to 1 ml and spun. The supernatant was used for checking the binding of 
[125I] -oLH and [125I] -oFSH by the procedure described above. All the binding data 
were normalised to undiluted serum.
 
Scatchard plot analysis
 
Affinity constants and capacity measurements of antisera were carried out by 
analysing the standard displacement profile for the hormone by Scatchard plot. 
Displacement analysis was carried out by standard procedure. In analysing the data, 
correction for the damage of the [125I]-hormone during iodination/storage was 
applied as already described (Murthy and Friesen, 1985a,b).
Hormones used as antigens are henceforth referred to as antigens and the 
complementary hormone (hormone sharing the same α-subunit) is referred to as 
antigen analogue. Thus, for oLH (antigen) oFSH is the antigen analogue and vice 
versa. 
 
Results 
 
Figure 1 shows the binding of oFSH antisera to [125I]-oFSH and [125I]-oLH. It is 
seen that the binding of the antigen is very much more than the antigen analogue. 
The extent of cross reaction was calculated from such a plot and the data for 5 
 
 
Figure 1. Binding of [125I]-oFSH (a) and [125I]-oLH (b) to oFSH antisera (Μ 428) at 
varying dilutions of the antisera. 
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antisera are shown in table 1. The cross reactivity is obviously small (2–4%), but 
definite, clearly demonstrating that the antibody raised to a antigen (in this case oLH 
or oFSH) can give rise to a population of antibodies, albeit small, which can bind to 
antigen analogue. 
 
Table 1. Specificity of binding of antisera raised to pure hormones. 
 
Figure 2 shows the binding characteristics of the oLH antiserum and oLH 
antiserum adsorbed on oLH-EPS (5 and 50 mg). A decrease in the binding ability for 
oLH as well as oFSH is seen. Relative loss of the binding ability to the hormones 
after adsorption with oLH-EPS is shown in table 2, for the two antisera. In all the 4 
cases the relative losses are same for both oLH and oFSH. These data clearly 
support the hypothesis that the cross reactivity that is observed in the antisera is due 
to the presence of the antibody population directed against common epitope/s 
between the two hormones.
 
 
Figure 2. Binding of [125I]-oLH (A) and [125I]-oFSH (B) to oLH antiserum (R 68). Curve 
'a' represents the binding of control antiserum and curve 'b' binding of the antiserum treated 
with 25 µl of oLH-EPS. The antiserum concentrations on the X-axis are normalised to 
undiluted serum. 
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Table 2. Adsorption efficiency of the oLH antibodies
by oLH–EPS. 
 
Figure 3 presents the displacement profile of oLH antisera for oLH and oFSH.
The inset presents corresponding Scatchard plot. Figure 4 shows the displace- 
ment profile for oLH antisera for both oLH and hCG, with corresponding Scat- 
chard plots in the inset. It is seen that while the Scatchard plot is clearly linear 
for oLH it is nonlinear for hCG, showing two sets of affinity constants. This type of 
analysis has been done for a number of antisera and the results are presented in table 
3. The data indicate the capacity as well as the apparent Ka for different hormone 
systems. As a general rule, the Ka for the antigen (hormone) is always very high 
compared to the antigen analogue. Likewise the capacity is also the highest for the 
antigen. The decrease in the Ka for the antigen analogues ranges from 2–20 fold, 
decrease in capacities being 10–40%. It should be noted here that the crossreactivity 
of these antisera were <4% with the antigen analogue. Another point to be 
 
Figure 3. Competitive binding assay of oLH antiserum (R 68) for oLH. A. [125I]-oLH, 
oLH for displacement at antiserum dilution of 1/25000 and for oFSH. B. [125I]-oFSH, 
oFSH for displacement at antiserum dilution of 1/500. The inset in each show corres- 
ponding Scatchard plots. 
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Figure 4. Competitive binding assay of oLH antiserum (Μ 471) to oLH. A. [125I]-oLH, 
oLH for displacement at antiserum dilution of 1/25000 and to hCG. B. [125I]-hCG, hCG 
for displacement at antiserum dilution of 1/500. The inset shows the corresponding 
Scatchard plots. 
 
 
 
Table 3. Scatchard plot analysis of displacement profile of different antisera*.
*Capacity is measured as μg/ml and K a presents affinity constant ×10–10. 
 
 
observed is that in all cases of antigen-antibody interaction, the Scatchard plots 
show a single affinity, whereas in some antigen analogue-antibody systems two 
affinity constants are observed.
 
Discussion 
 
On the basis that an immunological approach has a likely application in human 
fertility regulation it becomes very important to learn more about the nature of the 
crossreaction one can see in the antisera raised to pure hormones. One of the obser- 
vations that always presented problems to the investigators in the field of reproduc-
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tive physiology has been the immunological crossreactivity for many antisera raised
to gonadotropins. This has been mostly ascribed as due to antigenic impurity. The
data presented here clearly demonstrates that antiserum to a very pure antigen
crossreacts with antigen analogue, and this is seen for antisera obtained from
different species of animals (rabbit, monkey and goat). Thus the reason for this cross
reaction should be advanced on the basis of structure, and as such the most likely
possibility is the common structure of α-subunit between the two hormones, the ß-
subunits being noncrossreacting (Sairam, 1983). Binding data using Scatchard
analysis indicate that the crossreactivity is infact, while looking quite insignificant
looks much more alarming when actual quantiation of the antibody capacity is done.
We see that nearly 10–40% of the total capacity is directed against epitopes present
in the antigen analogue, though on simple binding data it looks only about <4%.
The other point to be considered is that in most of the cases the affinity constant for
the antigen is 2–20 times more than for the antigen analogue. On this basis one can
conclude that there are common epitopic regions between the antigen and the
analogue (in this case oLH and oFSH). The decrease in the Ka for antigen analogue
indicates that though the epitopes are common, they may not be identically disposed
sterically or otherwise. It is observed that all the antisera tested so far have given a 
single Ka for the antigen, but occassional multiple affinity constants for the antigen 
analogue (figure 4, table 3) are seen, clearly establishing a steric block or a 
conformational change at the epitopic sites in the antigen analogue with respect to 
the antigen. Thus, combination of α-subunit with different β-subunits results in a 
conformational change of the exposed α-subunit portion between the antigen and 
antigen analogue. This change could be either a steric blocking of the epitopic site or 
a subtle conformational change at the epitopic site itself. Thus, even though the 
primary structure of the α-subunit is the same around the epitopes, the 3 dimensional 
structure of these sequences is differentially altered by the combination with different 
β-subunits. The data of Hojo and Ryan (1985) from monoclonal antibodies to 
human FSH (hFSH) also indicate that an antibody to an epitope located at the α- 
subunit binds poorer to the free α-subunit than that in the native hFSH. Likewise it 
is seen in our laboratory that monoclonal antibodies to hCG bind to native hormone 
better than individual subunits (Rajan Dighe, unpublished results).
The other question raised because of the crossreacting nature of the antibody 
elicited to pure hormone is whether the antisera to oFSH can neutralise oLH. The 
data available in the literature (Rao and Moudgal, 1970; Moudgal et al., 1985) 
indicate that an antisera raised to one hormone is quite specific to that hormone as 
measured by its bioactivity or bioneutralising activity, under the conditions tested. 
The reason for this good specificity in bioactivity could be that either the hormone- 
antibody complex formed through the common epitope is biologically 
noninhibitory, or because of lower affinity for the antigen analogue, the analogue- 
antibody complex formation between the antigen analogue and antibody is 
insignificant. As of now there is no positive experimental proof to decide the issue 
and further experiments are in progress towards this end.
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